TITLE

Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma

AUTHOR(S)
Suissa, S.; Ernst, P.; Kezouh, A.
PUB. DATE
October 2002
SOURCE
Thorax;Oct2002, Vol. 57 Issue 10, p880
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Inhaled corticosteroids are effective at preventing asthma morbidity and mortality. Most studies, however, have focused on short term effects, raising uncertainty about their effectiveness in the long term. Methods: The Saskatchewan Health databases were used to form two population based cohorts of asthma patients aged 5-44 between 1975 and 1991. The first cohort included all subjects from the start of asthma treatment, while the second included subjects hospitalised for asthma from the date of discharge. Subjects were followed up, starting 1 year after cohort entry and continuing until 1997, 54 years of age, or death. The outcome was the first asthma hospital admission and readmission, respectively, to occur during follow up. A nested case-control design was used by which all cases were matched on calendar time and several markers of asthma severity to all available controls within the cohort. Results: The full cohort included 30569 asthmatic subjects of which 3894 were admitted to hospital for asthma and 1886 were readmitted. The overall rate of asthma hospitalisation was 42.4 per 1000 asthma patients per year. Regular use of inhaled corticosteroids was associated with reductions of 3 1 % in the rate of hospital admissions for asthma (95% confidence interval (Cl) 1 7 to 43) and 39% in the rate of readmission (95% Cl 25 to 50). The rate reduction found during the first 4 years of follow up was sustained over the longer term. Regular use of inhaled corticosteroids can potentially prevent between five hospital admissions and 27 readmissions per 1000 asthma patients per year. Conclusion: Regular use of low dose inhaled corticosteroids prevents a large proportion of hospital admissions with asthma, both early and later on in the course of the disease.
ACCESSION #
16181812

 

Related Articles

  • Use of inhaled corticosteroids during pregnancy and risk of pregnancy induces hypertension: Nested case-control. Martel, Marie-Josée; Rey, Évelyne; Beauchesne, Marie-France; Perreault, Sylvie; LeFebvre, Geneviève; Forget, Amélie; Blais, Lucie // BMJ: British Medical Journal (International Edition);1/29/2005, Vol. 330 Issue 7485, p230 

    Objective To determine whether the use of inhaled corticosteroids during pregnancy increases the risk of pregnancy induced hypertension and pre-eclampsia among asthmatic women. Design Nested case-control study. Setting Three administrative health databases from Quebec: RAMQ, MED-ECHO, and...

  • Canadian Pediatric Asthma Consensus Guidelines, 2003 (updated to December 2004). Becker, Allan; Bérube, Denis; Chad, Zave; Dolovich, Myrna; Ducharme, Francine; D'Urzo, Tony; Ernst, Pierre; Ferguson, Alexander; Gillespie, Cathy; Kapur, Sandeep; Kovesi, Tom; Lyttle, Brian; Mazer, Bruce; Montgomery, Mark; Pedersen, Soren; Pianosi, Paul; Reisman, John Joseph; Sears, Malcolm; Simons, Estelle; Spier, Sheldon // CMAJ: Canadian Medical Association Journal Supplement;9/1/2005, Vol. 173 Issue 6, pS12 

    Background: Although guidelines for the diagnosis and management of asthma have been published over the last 15 years, there has been little focus on issues relating to asthma in childhood. Since the last revision of the 1999 Canadian asthma consensus report, important new studies, particularly...

  • Pharmacotherapy -- add-on therapies.  // CMAJ: Canadian Medical Association Journal Supplement;9/1/2005, Vol. 173 Issue 6, pS37 

    Explores several add-on therapies for asthma. Advantage of using inhaled corticosteroids to children with asthma; Results of a study which examined the effectiveness of adding a salmeterol or formoterol compared with doubling the dose of inhaled steroid; Implications of the studies of add-on...

  • Inhalation devices and propellants.  // CMAJ: Canadian Medical Association Journal;11/30/99 Supplement, Vol. 161, pS44 

    The article focuses on the recommendations for the use of inhalation devices and propellants for asthma in children and adults. The article offers guidelines for the use of inhalation devices including pressurized metered-dose inhalers, metered-dose inhalers with spacers, dry-powder inhalers and...

  • Take a deep breath. Jenkins, Alison // Nursing Standard;3/1/2006, Vol. 20 Issue 25, p32 

    The article reflects on the ineffective medication of asthma patients due to inability to use inhalers correctly. It asserts that instead of focusing on complex goals, medical personnel should strive to get the basics right. In addition, it suggests that teaching patients on the basic about...

  • A prospective observational study of patient training in use of the autohaler inhaler device: the Sirocco Study. GIRAUD, V.; ALLAERT, F. A.; MAGNAN, A. // European Review for Medical & Pharmacological Sciences;2011, Vol. 15 Issue 5, p563 

    Background: Asthma guidelines recommend that patients receive inhaler technique training, with rechecks at each visit. However, sub-optimal inhaler technique is common. Methods: This prospective observational study evaluated patient training in use of the Autohaler , a breath-actuated...

  • Long-Acting Beta agonists and their relation to increased Asthma Morbidity and Mortality. The FDA Meta-Analysis. Pesola, Gene R.; Lone, Tahir; Gosala, Ramani // Internet Journal of Asthma, Allergy & Immunology;2008, Vol. 7 Issue 1, p1 

    The article presents a case study of asthma to examine whether or not long-acting beta agonists (LABAs) increase the risk of asthma morbidity and possibly mortality. An increase above baseline risk for asthma death is revealed in the results of the combined studies. The study found that except...

  • Long acting β2 agonists in adult asthma. Currie, Graeme P.; Small, Iain; Douglas, Graham // BMJ: British Medical Journal;10/5/2013, Vol. 347 Issue 7927, p32 

    The article discusses long acting β2 agonists (LABA) as treatment for asthma in adults. A case of a 30-year old man with asthma is presented. Studies show that add-on LABAs help reduce symptoms, relief inhaler use and improve lung function. Adverse effects of LABAs include tachycardia,...

  • Second opinion.  // Mayo Clinic Health Letter;Feb2013, Vol. 31 Issue 2, p8 

    The article presents questions and answers related to medical issues including is an inhaled steroid or the quick-relief inhaler better for asthama, and how can a person have too much thyroid and be fatigued at the same time.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics